METASTATIC PANCREATIC CARCINOMA
Clinical trials for METASTATIC PANCREATIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heated chemo bath tested for advanced pancreatic cancer
Disease control Recruiting nowThis study is testing a procedure called HIPEC, which delivers heated chemotherapy directly into the abdomen, for people with pancreatic cancer that has spread to the abdominal lining. The goal is to see if this approach helps patients live longer and controls the cancer better t…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New trial tests if switching PARP inhibitors can help control advanced cancers
Disease control Recruiting nowThis study is testing whether the drug talazoparib can help control advanced cancers in patients whose tumors have specific mutations in genes that help repair DNA damage. It is enrolling 36 adults with various advanced solid tumors (like breast, ovarian, prostate, pancreatic, an…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo targets Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing the safety and effectiveness of a new two-drug combination for people with advanced solid tumors, including pancreatic cancer, that have spread or stopped responding to standard treatments. The trial aims to find the best dose and see if the drugs can help c…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for tough pancreatic cancer? trial targets key mutation
Disease control Recruiting nowThis study is testing a new combination of drugs for people with advanced pancreatic cancer that has spread and has a specific genetic change called KRAS G12D. The goal is to see if adding a new drug called HRS-4642 to standard chemotherapy and another targeted drug can better co…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Remote trial tests targeted pill for tough pancreatic cancer
Disease control Recruiting nowThis study is testing an oral drug called pemigatinib for adults with advanced pancreatic cancer that has specific genetic changes (FGFR alterations). The goal is to see if blocking these abnormal genes can stop tumor growth and improve quality of life. The trial is conducted ful…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists watch Cancer's blood supply live during surgery
Knowledge-focused Recruiting nowThis study aims to learn more about the tiny blood vessels that feed solid tumors. Researchers will use a special microscope during a patient's standard cancer surgery to see these vessels in real time. The goal is to understand how tumor blood flow works and if it relates to how…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC